[{"Assets_0_FY_USD":8318465000.0,"EarningsPerShareDiluted_4_FY_USD":4.51,"EarningsPerShareDiluted_1_FY_USD":2.23,"WeightedAverageNumberOfSharesOutstandingBasic_1_FY_shares":258003000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":256728000.0,"EarningsPerShareBasic_1_FY_USD":2.26,"EarningsPerShareBasic_4_FY_USD":4.58,"RevenuesConverted_4_FY_USD":4162821000.0,"StockholdersEquityConverted_0_FY_USD":6085244000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":260673000.0,"NetIncomeLossConverted_4_FY_USD":1176810000.0,"NetIncomeLossConverted_1_FY_USD":583234000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":1569330000.0,"CommonStockSharesOutstanding_0_FY_shares":258993000.0,"CommonStockSharesConverted_0_FY_shares":258993000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_FY_shares":262108000.0,"RevenuesConverted_1_FY_USD":1413265000.0,"Ticker":"VRTX","CIK":"875320","name":"VERTEX PHARMACEUTICALS INC \/ MA","OfficialName":"Vertex Pharmaceuticals Incorporated Common Stock","form":"10-K","period":"20191231","fy":"2019.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"72193451271.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20200213"}]